Literature DB >> 16610006

Clinical features of hepatopulmonary syndrome in cirrhotic patients.

Amir Houshang Mohammad Alizadeh1, Seyed Reza Fatemi, Vahid Mirzaee, Manoochehr Khoshbaten, Bahman Talebipour, Afsaneh Sharifian, Ziba Khoram, Farhad Haj-sheikh-oleslami, Masoomeh Gholamreza-shirazi, Mohammad Reza Zali.   

Abstract

AIM: To evaluate the frequency, clinical and paraclinical features of hepatopulmonary syndrome (HPS) and to determine their predictive values in diagnosis of this syndrome in patients in Iran.
METHODS: Fifty four cirrhotic patients underwent contrast enhanced echocardiography to detect intrapulmonary and intracardiac shunts by two cardiologists. Arterial blood oxygen, O(2) gradient (A-a) and orthodoxy were measured by arterial blood gas (ABG) test. The patients positive for diagnostic criteria of HPS were defined as clinical HPS cases and those manifesting the intrapulmonary arterial dilation but no other criteria (arterial blood hypoxemia) were defined as lHPS cases. HPS frequency, sensitivity, positive and negative predictive values of clinical and paraclinical features were studied.
RESULTS: Ten (18.5%) and seven (13%) cases had clinical and subclinical HPS, respectively. The most common etiology was hepatitis B. Dyspnea (100%) and cyanosis (90%) were the most prevalent clinical features. Dyspnea and clubbing were the most sensitive and specific clinical features respectively. No significant relationship was found between HPS and splenomegaly, ascites, edema, jaundice, oliguria, and collateral veins. HPS was more prevalent in hepatitis B. PaO(2)< 70 and arterial-alveolar gradient had the highest sensitivity in HPS patients. Orthodoxy specificity was 100%.
CONCLUSION: Clubbing with positive predictive value (PPV) of 75% and dyspnea with negative predictive value (NPV) of 75% are the best clinical factors in diagnosis of HPS syndrome. PaO(2)< 70 and P (A-a) O(2)> 30 and their sum, are the most valuable negative and positive predictive values in HPS patients.

Entities:  

Mesh:

Year:  2006        PMID: 16610006      PMCID: PMC4087525          DOI: 10.3748/wjg.v12.i12.1954

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  7 in total

1.  Hepatopulmonary syndrome: prevalence and clinical profile.

Authors:  A C Anand; D Mukherjee; K S Rao; A K Seth
Journal:  Indian J Gastroenterol       Date:  2001 Jan-Feb

2.  Diagnosis of hepatopulmonary syndrome with contrast transesophageal echocardiography: advantages over contrast transthoracic echocardiography.

Authors:  R Aller; J L Moya; V Moreira; D Boixeda; A Cano; J Picher; S García-Rull; D A de Luis
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

3.  Hepatopulmonary syndrome: prevalence and predictive value of various cut offs for arterial oxygenation and their clinical consequences.

Authors:  P Schenk; V Fuhrmann; C Madl; G Funk; S Lehr; O Kandel; C Müller
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

4.  Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis.

Authors:  Peter Schenk; Maximilian Schöniger-Hekele; Valentin Fuhrmann; Christian Madl; Gerd Silberhumer; Christian Müller
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

5.  A study of hepatopulmonary syndrome among patients of cirrhosis of liver and portal hypertension.

Authors:  H S Hira; Jaya Kumar; S K Tyagi; S K Jain
Journal:  Indian J Chest Dis Allied Sci       Date:  2003 Jul-Sep

6.  Evaluation of contrast echocardiography and lung perfusion scan in detecting intrapulmonary vascular dilatation in normoxemic patients with early liver cirrhosis.

Authors:  K P Mimidis; P I Vassilakos; A N Mastorakou; K V Spiropoulos; C A Lambropoulou-Karatza; K C Thomopoulos; K N Tepetes; V N Nikolopoulou
Journal:  Hepatogastroenterology       Date:  1998 Nov-Dec

7.  Frequency, clinical characteristics, and respiratory parameters of hepatopulmonary syndrome.

Authors:  Beatriz L G Lima; Alex V C França; Antonio Pazin-Filho; Whemberton M Araújo; José A B Martinez; Benedito C Maciel; Marcus V Simões; João Terra-Filho; Ana L C Martinelli
Journal:  Mayo Clin Proc       Date:  2004-01       Impact factor: 7.616

  7 in total
  17 in total

Review 1.  Differential diagnosis of hepatopulmonary syndrome (HPS): Portopulmonary hypertension (PPH) and hereditary hemorrhagic telangiectasia (HHT).

Authors:  Inna Krynytska; Mariya Marushchak; Anna Mikolenko; Anzhela Bob; Iryna Smachylo; Ludmyla Radetska; Olga Sopel
Journal:  Bosn J Basic Med Sci       Date:  2017-11-20       Impact factor: 3.363

Review 2.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

3.  Clinical significance of a myeloperoxidase gene polymorphism and inducible nitric oxide synthase expression in cirrhotic patients with hepatopulmonary syndrome.

Authors:  Yanying Wang; Wenduo Wang; Yanxia Zhang; Xin Zhao; Dongliang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

4.  Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.

Authors:  Ki Tae Suk; Moon Young Kim; Soung Won Jeong; Jae Young Jang; Yoon Ok Jang; Soon Koo Baik
Journal:  Dig Dis Sci       Date:  2017-12-01       Impact factor: 3.199

Review 5.  Cirrhosis and hepatopulmonary syndrome.

Authors:  Gokhan Tumgor
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

6.  Dyspnea and respiratory muscle strength in end-stage liver disease.

Authors:  Georgios Kaltsakas; Efstathios Antoniou; Anastasios F Palamidas; Sofia-Antiopi Gennimata; Panorea Paraskeva; Anastasios Smyrnis; Antonia Koutsoukou; Joseph Milic-Emili; Nickolaos G Koulouris
Journal:  World J Hepatol       Date:  2013-02-27

7.  Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran.

Authors:  Mohammad Amin Behzadi; Mazyar Ziyaeyan; Sadaf Asaei
Journal:  Jundishapur J Microbiol       Date:  2014-05-01       Impact factor: 0.747

Review 8.  Current concepts in the management of hepatopulmonary syndrome.

Authors:  Vincent Ho
Journal:  Vasc Health Risk Manag       Date:  2008

9.  Etiology of Portal Hypertension in Children:A Single Center's Experiences.

Authors:  Mohammad Hadi Imanieh; Seyed Mohsen Dehghani; Maryam Khoshkhui; Abdorrasoul Malekpour
Journal:  Middle East J Dig Dis       Date:  2012-10

10.  Left Ventricular Dilation and Pulmonary Vasodilatation after Surgical Shunt for Treatment of Pre-Sinusoidal Portal Hypertension.

Authors:  Orlando Luis de Andrade Santarém; Roberto de Cleva; Flávia Megumi Sasaya; Marianna Siqueira de Assumpção; Meive Santos Furtado; Alfonso Julio Guedes Barbato; Paulo Herman
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.